Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2017 1
2018 1
2019 1
2020 1
2022 5
2023 14
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean yipeng gao[Author] (20 results)?
Chidamide maintenance therapy in high-risk T-ALL/T-LBL after allo-HSCT: a prospective, single-center, single-arm study.
Guo W, Cao Y, Liu J, Zheng X, Wang M, Zheng Y, Zhang X, Zhai W, Chen X, Zhang R, Ma Q, Yang D, Wei J, He Y, Pang A, Feng S, Han M, Jiang E. Guo W, et al. Among authors: cao y. Bone Marrow Transplant. 2023 Oct;58(10):1163-1166. doi: 10.1038/s41409-023-02045-w. Epub 2023 Jul 20. Bone Marrow Transplant. 2023. PMID: 37474728 No abstract available.
Dynamic forecasting of severe acute graft-versus-host disease after transplantation.
Liu X, Cao Y, Guo Y, Gong X, Feng Y, Wang Y, Wang M, Cui M, Guo W, Zhang L, Zhao N, Song X, Zheng X, Chen X, Shen Q, Zhang S, Song Z, Li L, Feng S, Han M, Zhu X, Jiang E, Chen J. Liu X, et al. Among authors: cao y. Nat Comput Sci. 2022 Mar;2(3):153-159. doi: 10.1038/s43588-022-00213-4. Epub 2022 Mar 28. Nat Comput Sci. 2022. PMID: 38177449 Free PMC article.
The Composite Immune Risk Score predicts overall survival after allogeneic hematopoietic stem cell transplantation: A retrospective analysis of 1838 cases.
Cao Y, Gong X, Feng Y, Wang M, Hu Y, Liu H, Liu X, Qi S, Ji Y, Liu F, Zhu H, Guo W, Shen Q, Zhang R, Zhao N, Zhai W, Song X, Chen X, Geng L, Chen X, Zheng X, Ma Q, Tang B, Wei J, Huang Y, Ren Y, Song K, Yang D, Pang A, Yao W, He Y, Shang Y, Wan X, Zhang W, Zhang S, Sun G, Feng S, Zhu X, Han M, Song Z, Guo Y, Sun Z, Jiang E, Chen J. Cao Y, et al. Am J Hematol. 2023 Feb;98(2):309-321. doi: 10.1002/ajh.26792. Epub 2023 Jan 2. Am J Hematol. 2023. PMID: 36591789 Free PMC article.
Author Correction: Dynamic forecasting of severe acute graft-versus- host disease after transplantation.
Liu X, Cao Y, Guo Y, Gong X, Feng Y, Wang Y, Wang M, Cui M, Guo W, Zhang L, Zhao N, Song X, Zheng X, Chen X, Shen Q, Zhang S, Song Z, Li L, Feng S, Han M, Zhu X, Jiang E, Chen J. Liu X, et al. Among authors: cao y. Nat Comput Sci. 2022 May;2(5):342. doi: 10.1038/s43588-022-00256-7. Nat Comput Sci. 2022. PMID: 38177828 Free PMC article. No abstract available.
JAK1/2 inhibitor ruxolitinib promotes the expansion and suppressive action of polymorphonuclear myeloid-derived suppressor cells via the JAK/STAT and ROS-MAPK/NF-κB signalling pathways in acute graft-versus-host disease.
Cao Y, Wang J, Jiang S, Lyu M, Zhao F, Liu J, Wang M, Pei X, Zhai W, Feng X, Feng S, Han M, Xu Y, Jiang E. Cao Y, et al. Clin Transl Immunology. 2023 Feb 25;12(2):e1441. doi: 10.1002/cti2.1441. eCollection 2023. Clin Transl Immunology. 2023. PMID: 36855558 Free PMC article.
Efficacy of venetoclax combined with decitabine conditioning regimen for allogeneic hematopoietic stem cell transplantation in high-risk and elderly patients with myeloid neoplasms.
Zheng X, Gao H, Lu N, Wang M, Zhang H, Zheng Y, Shen B, Cao Y, Chen X, Zhai W, Wei J, Yang D, Zhang R, Pang A, Feng S, Jiang E, Han M. Zheng X, et al. Among authors: cao y. Ann Hematol. 2023 Dec;102(12):3603-3611. doi: 10.1007/s00277-023-05500-2. Epub 2023 Oct 25. Ann Hematol. 2023. PMID: 37878011
Proteinase 3 depletion attenuates leukemia by promoting myeloid differentiation.
Liu H, Sun L, Zhao H, Zhao Z, Zhang S, Jiang S, Cheng T, Wang X, Wang T, Shao Y, Zhu H, Han H, Cao Y, Jiang E, Cao Y, Xu Y. Liu H, et al. Among authors: cao y. Cell Death Differ. 2024 Apr 8. doi: 10.1038/s41418-024-01288-4. Online ahead of print. Cell Death Differ. 2024. PMID: 38589495
26 results